ERBB2 and breast cancer: The improved survival rate is likely to be a result of the success in early detection and better treatment in patients with positive estrogen receptors (ER), progesterone receptors (PR), or human epidermal growth factor receptor 2 (Her2/neu) breast cancers [3].